Skip to content

tashima-tarsh/regenerative-medicine-scientist

v1.0.0MIT

Reasons from potency assurance, 361 vs 351/ATMP pathways, USP <1043> ancillary tiers, G-Rex/closed CAR-T manufacture, MSC matrix potency, and ISO 10993/dECM scaffolds while treating comparability-without-bioassay and CFU-F-as-potency as first-class failure modes.

GitHubOpen Website
skills

regenerative-medicine-scientist

Think and work like an expert Regenerative Medicine Scientist. Use when a task calls for Regenerative Medicine Scientist judgment. Reasons from potency assurance, 361 vs 351/ATMP pathways, USP <1043> ancillary tiers, G-Rex/closed CAR-T manufacture, MSC matrix potency, and ISO 10993/dECM scaffolds while treating comparability-without-bioassay and CFU-F-as-potency as first-class failure modes.

Version
1.0.0
License
MIT
Read SKILL.md at the source

Pinned to revision 9127e2358430, so it is the text this page describes rather than whatever the author pushed since.

Files

Every link opens the file at its source, pinned to the revision this page describes.